Literature DB >> 10720504

Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

J Izopet1, L Rostaing, K Sandres, J M Cisterne, C Pasquier, J L Rumeau, M Duffaut, D Durand, J Puel.   

Abstract

The pathogenesis of hepatitis C virus (HCV) infection was investigated by analysis of changes in viral and histologic parameters in 36 renal transplant recipients who were infected with HCV before transplantation. Each patient was classified according to development of liver fibrosis as assessed by 2 liver biopsies done 45 and 81 months after transplantation: 13 had progressing liver fibrosis (fibrosers) and 23 did not (nonfibrosers). All developed high-titer posttransplant viremia with a significant increase of 1.2 log RNA copies/mL. There were no significant differences in the increases in serum HCV RNA or genotype distributions in fibrosers and nonfibrosers. The hypervariable region (HVR)-1 of the HCV genome was analyzed by cloning and sequencing 20 clones per sample from 5 fibrosers and 5 nonfibrosers. Comparison of samples revealed that liver fibrosis progression was significantly associated with slower HVR-1 quasispecies diversification, suggesting the selection of more aggressive variants in fibrosers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720504     DOI: 10.1086/315355

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Management of patients with hepatitis C infection and renal disease.

Authors:  Chalermrat Bunchorntavakul; Monthira Maneerattanaporn; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Chronic viral hepatitis in kidney transplantation.

Authors:  Janna Huskey; Alexander C Wiseman
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

Review 3.  Hepatitis C infection in hemodialysis patients: A review.

Authors:  Digdem Ozer Etik; Serkan Ocal; Ahmet Sedat Boyacioglu
Journal:  World J Hepatol       Date:  2015-04-28

4.  The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients.

Authors:  Kazuaki Okino; Yuki Okushi; Kiyotaka Mukai; Yuki Matsui; Norifumi Hayashi; Keiji Fujimoto; Hiroki Adachi; Hideki Yamaya; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2017-03-29       Impact factor: 2.801

5.  Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients.

Authors:  Sebastien Lhomme; Florence Abravanel; Martine Dubois; Karine Sandres-Saune; Lionel Rostaing; Nassim Kamar; Jacques Izopet
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

6.  Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.

Authors:  Xiao-Hong Wang; Dale M Netski; Jacquie Astemborski; Shruti H Mehta; Michael S Torbenson; David L Thomas; Stuart C Ray
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

7.  HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirin.

Authors:  Wyel Hakim; Shehzad Sheikh; Irteza Inayat; Cary Caldwell; Douglas Smith; Marc Lorber; Amy Friedman; Dhanpat Jain; Margaret Bia; Richard Formica; Wajahat Mehal
Journal:  J Clin Gastroenterol       Date:  2009 May-Jun       Impact factor: 3.062

Review 8.  Hepatitis C and its impact on renal transplantation.

Authors:  Jose M Morales; Fabrizio Fabrizi
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

9.  Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).

Authors:  Tomasz Laskus; Jeffrey Wilkinson; Roksana Karim; Wendy Mack; Marek Radkowski; Marina deGiacomo; Jonathan Nasseri; Zhi Chen; Jiaao Xu; Andrea Kovacs
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

Review 10.  Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon.

Authors:  Sara Belga; Karen Elizabeth Doucette
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.